News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
133 Results
Type
Article (10)
Company Profile (1)
Press Release (122)
Section
Business (41)
Deals (3)
Drug Development (27)
FDA (4)
Job Trends (2)
News (64)
Policy (3)
Tag
Alliances (5)
Approvals (4)
Autoimmune disease (2)
Best Places to Work (2)
Biotechnology (1)
Cancer (7)
CAR-T (1)
Cell therapy (3)
Clinical research (20)
C-suite (1)
Data (7)
Earnings (16)
Events (38)
Executive appointments (1)
FDA (5)
GLP-1 (1)
Healthcare (41)
Immunology and inflammation (1)
IPO (3)
Lung cancer (2)
Lymphoma (6)
Mergers & acquisitions (2)
NextGen: Class of 2026 (4)
People (24)
Phase 1 (13)
Phase 2 (15)
Phase 3 (1)
Pipeline (7)
Preclinical (3)
Real estate (3)
Regulatory (4)
Startups (2)
Date
Last 30 days (1)
Last 365 days (18)
2026 (2)
2025 (17)
2024 (35)
2023 (30)
2022 (24)
2021 (16)
2020 (4)
2019 (3)
2017 (1)
Location
Asia (3)
Australia (1)
California (28)
Europe (49)
Northern California (1)
Southern California (26)
United States (28)
133 Results for "artiva biotherapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November 2025
October 31, 2025
·
3 min read
Press Releases
Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 13, 2025
·
9 min read
Press Releases
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL
January 21, 2026
·
4 min read
Press Releases
Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease
November 13, 2025
·
9 min read
Press Releases
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
October 17, 2025
·
8 min read
Press Releases
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025
August 26, 2025
·
3 min read
Press Releases
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
November 3, 2025
·
4 min read
Business
Updated: Artiva’s IPO Jumps to $167M
Cell therapy biotech Artiva Biotherapeutics plans to use the funds raised to support the development of its AlloNK therapy for systemic lupus erythematosus.
July 19, 2024
·
2 min read
·
Tyler Patchen
Press Releases
Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights
August 7, 2025
·
8 min read
Press Releases
Artiva Biotherapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
May 29, 2025
·
3 min read
1 of 14
Next
